Gehrmann, Mathias <br/><br/>
Prediction of paclitaxel resistance in breast cancer: is CYP1B1*3 a new factor of influence?  [electronic resource] 

 -  Pharmacogenomics  Jul 2008 
 - 969-74 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1744-8042 
<br/><br/><label>Standard No.: </label>10.2217/14622416.9.7.969  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Aryl Hydrocarbon Hydroxylases<br/>Breast Neoplasms--drug therapy<br/>Cytochrome P-450 CYP1B1<br/>Cytochrome P-450 Enzyme System--genetics<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Humans<br/>Paclitaxel--administration & dosage<br/>Polymorphism, Genetic